138 related articles for article (PubMed ID: 8037585)
1. [Expression and co-expression of cellular oncogenes in the course of tumor progression in neuroendocrine lung tumors].
Kogan EA; Shtabskiĭ AB; Sekamova SM; Sukhova NM; Mazurenko NN
Arkh Patol; 1994; 56(2):16-21. PubMed ID: 8037585
[TBL] [Abstract][Full Text] [Related]
2. [Peripheral small cell carcinoma, atypical and typical lung carcinoids (morphologic features, cell oncogene expression, DNA histospectrophotometry)].
Kogan EA; Sekamova SM; Mazurenko NN; Bogatyrev VN
Arkh Patol; 1991; 53(7):42-8. PubMed ID: 1683768
[TBL] [Abstract][Full Text] [Related]
3. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
4. Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung.
Spandidos DA; Zakinthinos S; Petraki C; Sotsiou F; Yiagnisis M; Dimopoulos AM; Roussos C; Field JK
Anticancer Res; 1990; 10(5A):1105-14. PubMed ID: 2173469
[TBL] [Abstract][Full Text] [Related]
5. Oncogene expression in gastroenteropancreatic neuroendocrine tumors: implications for pathogenesis.
Wang DG; Johnston CF; Buchanan KD
Cancer; 1997 Aug; 80(4):668-75. PubMed ID: 9264349
[TBL] [Abstract][Full Text] [Related]
6. [The immunohistochemistry of cellular oncogenes in precancer and cancer of the lung].
Kogan EA; Mazurenko NN; Iushkov PV; Trishkina NV; Kiselev FL
Arkh Patol; 1990; 52(8):3-11. PubMed ID: 2281984
[TBL] [Abstract][Full Text] [Related]
7. [Nuclear oncoprotein expression in lung precancer and cancer at various stages of tumor progression studies at the level of light- and electron-immunohistochemistry].
Kogan EA; Shtabskiĭ AB; Sekamova SM; Mazurenko NN; Kiselev FL
Arkh Patol; 1994; 56(6):44-9. PubMed ID: 7605217
[TBL] [Abstract][Full Text] [Related]
8. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
9. [Synthesis and distribution of oncoproteins in tumor tissue].
Mazurenko NN; Kogan EA; Sukhova NM; Zborovskaia IB
Vopr Med Khim; 1991; 37(6):53-9. PubMed ID: 1839874
[TBL] [Abstract][Full Text] [Related]
10. Differential retinoblastoma and p16(INK4A) protein expression in neuroendocrine tumors of the lung.
Dosaka-Akita H; Cagle PT; Hiroumi H; Fujita M; Yamashita M; Sharma A; Kawakami Y; Benedict WF
Cancer; 2000 Feb; 88(3):550-6. PubMed ID: 10649246
[TBL] [Abstract][Full Text] [Related]
11. Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas.
Bolon I; Gouyer V; Devouassoux M; Vandenbunder B; Wernert N; Moro D; Brambilla C; Brambilla E
Am J Pathol; 1995 Nov; 147(5):1298-310. PubMed ID: 7485393
[TBL] [Abstract][Full Text] [Related]
12. [Cell oncogene expression in normal, metaplastic, dysplastic epithelium and squamous cell carcinoma of the uterine cervix].
Petrov SV; Mazurenko NN; Sukhova NM; Moroz IP; Katsenel'son VM; Raĭkhlin NT; Kiselev FL
Arkh Patol; 1994; 56(4):22-31. PubMed ID: 7848100
[TBL] [Abstract][Full Text] [Related]
13. Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53.
Wang DG; Johnston CF; Sloan JM; Buchanan KD
J Pathol; 1998 Mar; 184(3):247-51. PubMed ID: 9614375
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein associated expression of c-fos and c-jun products in human lung carcinomas.
Volm M
Anticancer Res; 1993; 13(2):375-8. PubMed ID: 8100127
[TBL] [Abstract][Full Text] [Related]
15. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines.
Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G
Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933
[TBL] [Abstract][Full Text] [Related]
16. Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung.
Coppola D; Clarke M; Landreneau R; Weyant RJ; Cooper D; Yousem SA
Mod Pathol; 1996 May; 9(5):484-90. PubMed ID: 8733762
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.
Brambilla E; Negoescu A; Gazzeri S; Lantuejoul S; Moro D; Brambilla C; Coll JL
Am J Pathol; 1996 Dec; 149(6):1941-52. PubMed ID: 8952529
[TBL] [Abstract][Full Text] [Related]
18. Expression of the L-myc gene is under positive control by short-lived proteins.
Saksela K
Oncogene; 1987; 1(3):291-6. PubMed ID: 2838780
[TBL] [Abstract][Full Text] [Related]
19. Expression of the pro-opiomelanocortin gene in lung neuroendocrine tumours: in situ hybridization and immunohistochemical studies.
Black M; Carey FA; Farquharson MA; Murray GD; McNicol AM
J Pathol; 1993 Mar; 169(3):329-34. PubMed ID: 8388056
[TBL] [Abstract][Full Text] [Related]
20. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins.
Risse-Hackl G; Adamkiewicz J; Wimmel A; Schuermann M
Oncogene; 1998 Jun; 16(23):3057-68. PubMed ID: 9662339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
